Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Reiichiro Kuwahara"'
Autor:
Teruko Arinaga-Hino, Tatsuya Ide, Jun Akiba, Hiroyuki Suzuki, Reiichiro Kuwahara, Keisuke Amano, Toshihiro Kawaguchi, Tomoya Sano, Eisuke Inoue, Hironori Koga, Keiichi Mitsuyama, Yasutoshi Koga, Takuji Torimura
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract Growth differentiation factor 15 (GDF15) has been reported to be associated with fibrosis and cancer in liver disease. Diagnosis of autoimmune hepatitis (AIH) is often difficult because of the lack of specific markers. We investigated whethe
Externí odkaz:
https://doaj.org/article/2de8e2b04a794584bdc162282c1e7cda
Autor:
Hiroyuki Suzuki, Teruko Arinaga-Hino, Tomoya Sano, Yutaro Mihara, Hironori Kusano, Tatsuki Mizuochi, Takao Togawa, Shogo Ito, Tatsuya Ide, Reiichiro Kuwahara, Keisuke Amano, Toshihiro Kawaguchi, Hirohisa Yano, Masayoshi Kage, Hironori Koga, Takuji Torimura
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
Benign recurrent intrahepatic cholestasis type 1 (BRIC1) is a rare autosomal recessive disorder that is characterized by intermittent episodes of jaundice and intense pruritus and caused by pathogenic variants of adenosine triphosphatase phospholipid
Externí odkaz:
https://doaj.org/article/273337d8cf2a4d5f9cc9e33997d0884e
Autor:
Ryoko Kuromatsu, Tatsuya Ide, Shusuke Okamura, Yu Noda, Naoki Kamachi, Masahito Nakano, Tomotake Shirono, Shigeo Shimose, Hideki Iwamoto, Reiichiro Kuwahara, Teruko Arinaga-Hino, Takashi Niizeki, Yuki Zaizen, Hiroshi Takaki, Miki Shirachi, Hironori Koga, Takuji Torimura
Publikováno v:
Cancers, Vol 14, Iss 9, p 2295 (2022)
It remains unclear whether hepatocellular carcinoma (HCC) recurrence in hepatitis C virus (HCV)-infected patients can be suppressed by the elimination of the virus using direct-acting antivirals (DAAs) after radical HCC treatment. We evaluated the su
Externí odkaz:
https://doaj.org/article/1115f04088af4799aad9786be313da65
Autor:
Tomoya Sano, Takumi Kawaguchi, Tatsuya Ide, Keisuke Amano, Reiichiro Kuwahara, Teruko Arinaga-Hino, Takuji Torimura
Publikováno v:
Life, Vol 11, Iss 3, p 263 (2021)
Nucles(t)ide analogs (NAs) are effective for chronic hepatitis B (CHB). NAs suppress hepatic decompensation and hepatocarcinogenesis, leading to a dramatic improvement of the natural course of patients with CHB. However, renal dysfunction is becoming
Externí odkaz:
https://doaj.org/article/2ccc006a7ce9456f9ec8c3b6c1ffa3f0
Autor:
Tatsuya Ide, Yuichiro Eguchi, Masaru Harada, Kunihide Ishii, Masaru Morita, Yasuyo Morita, Gen Sugiyama, Hirofumi Fukushima, Yoichi Yano, Kazunori Noguchi, Hiroki Nakamura, Junjiro Hisatomi, Hiroto Kumemura, Miki Shirachi, Shinji Iwane, Michiaki Okada, Yuichi Honma, Teruko Arinaga-Hino, Ichiro Miyajima, Kei Ogata, Reiichiro Kuwahara, Keisuke Amano, Toshihiro Kawaguchi, Ryoko Kuromatsu, Takuji Torimura, DAAs Multicenter Study Group
Publikováno v:
PLoS ONE, Vol 11, Iss 9, p e0163884 (2016)
The aim of this study was to evaluate the efficacy of daclatasvir plus asunaprevir therapy in patients infected with hepatitis C virus and determine its relevance to resistant variants.A total of 629 consecutive patients infected with hepatitis C vir
Externí odkaz:
https://doaj.org/article/43826e91e146470a8ed457a5bb2b9989
Autor:
Hideki Iwamoto, Takuji Torimura, Toru Nakamura, Osamu Hashimoto, Kinya Inoue, Junichi Kurogi, Takashi Niizeki, Reiichiro Kuwahara, Mitsuhiko Abe, Hiromori Koga, Hirohisa Yano, Robert S. Kerbel, Takato Ueno, Michio Sata
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 13, Iss 3, Pp 187-197 (2011)
Background: Metronomic chemotherapy involves frequent, regular administration of cytotoxic drugs at nontoxic doses, usually without prolonged breaks. We investigated the therapeutic efficacies of metronomic S-1, an oral 5-fluorouracil prodrug, and va
Externí odkaz:
https://doaj.org/article/c4c89742d45e427cb9f56444dccd5816
Autor:
Tomoya Sano, Keisuke Amano, Tatsuya Ide, Keiji Yokoyama, Kazunori Noguchi, Hiroki Nakamura, Hiroshi Isoda, Miki Ohno, Miki Shirachi, Yasuyo Morita, Yoichi Yano, Shuji Sumie, Toshihiro Kawaguchi, Reiichiro Kuwahara, Teruko Arinaga‐Hino, Hirokazu Takahashi, Satoshi Shakado, Fumihito Hirai, Takumi Kawaguchi
Publikováno v:
Hepatology Research. 53:26-34
The real-world efficacy of sofosbuvir/velpatasvir treatment for patients with hepatitis C virus-related decompensated cirrhosis is unclear. We aimed to identify factors that improve liver functional reserve after treatment.This was a multicenter retr
Autor:
Hiroyuki Suzuki, Tomoya Sano, Yasumasa Shimasaki, Maki Yamaguchi, Tatsuya Ide, Teruko Arinaga-Hino, Reiichiro Kuwahara, Keisuke Amano, Koichi Oshima, Koji Nagafuji, Hiroaki Ida, Hironori Koga, Takuji Torimura
Publikováno v:
Internal medicine (Tokyo, Japan). 61(19)
Thrombocytopenia, anasarca, fever, reticulin fibrosis, and organomegaly (TAFRO) syndrome is a systemic inflammatory disorder characterized by the above-mentioned symptoms. Because of the similarity in phenotypes between TAFRO syndrome and decompensat
Autor:
Takuji Torimura, Takumi Kawaguchi, Reiichiro Kuwahara, Tomoya Sano, Tatsuya Ide, Keisuke Amano, Teruko Arinaga-Hino
Publikováno v:
Life, Vol 11, Iss 263, p 263 (2021)
Life
Life
Nucles(t)ide analogs (NAs) are effective for chronic hepatitis B (CHB). NAs suppress hepatic decompensation and hepatocarcinogenesis, leading to a dramatic improvement of the natural course of patients with CHB. However, renal dysfunction is becoming
Autor:
Tomoya Sano, Tatsuya Ide, Shirachi Miki, Teruko Hino, Naofumi Ono, Takuji Torimura, Toshihiro Kawaguchi, Reiichiro Kuwahara, Keisuke Amano
Publikováno v:
Molecular and Clinical Oncology
Advanced liver fibrosis is the most important risk factor for hepatocellular carcinoma (HCC) development after achieving sustained virological response (SVR) by direct-acting antiviral (DAA) treatment in patients with chronic hepatitis C. Wisteria fl